June 30, 2020 / 6:10 AM / 15 days ago

BRIEF-Oncopeptides Submits New Drug Application To FDA

June 30 (Reuters) - Oncopeptides AB:

* ONCOPEPTIDES SUBMITS A NEW DRUG APPLICATION TO THE FDA FOR ACCELERATED APPROVAL OF MELFLUFEN IN TRIPLE-CLASS REFRACTORY MULTIPLE MYELOMA PATIENTS

* FOLLOWING SUBMISSION TO FDA ONCOPEPTIDES WILL INITIATE AN EXPANDED ACCESS PROGRAM (EAP) IN U.S. TO ENABLE MELFLUFEN TREATMENT FOR PATIENTS WITH A SIGNIFICANT UNMET MEDICAL NEED Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below